Finn Radner
- Risks of diabetes mellitus and hyperglycaemic adverse events in patients with COPD taking inhaled corticosteroidsBy Stephen Rennard, Paul O'Byrne, Finn Radner, Stefan Peterson, Ella Ekholm, Bengt Lindberg and Don SinStephen Rennard1Internal Medicine Section of Pulmonary and Critical Care, University of Nebraska Medical Center, Omaha, United StatesPaul O'Byrne2Faculty of Health Sciences, Michael G DeGroote School of Medicine, Hamilton, CanadaFinn Radner3Department of Clinical Sciences, AstraZeneca Research and Development, Lund, SwedenStefan Peterson3Department of Clinical Sciences, AstraZeneca Research and Development, Lund, SwedenElla Ekholm3Department of Clinical Sciences, AstraZeneca Research and Development, Lund, SwedenBengt Lindberg3Department of Clinical Sciences, AstraZeneca Research and Development, Lund, SwedenDon Sin4Department of Medicine, University of British Columbia, Vancouver, Canada
- Safety of formoterol in asthma clinical trials: an updateBy Malcolm R. Sears and Finn RadnerMalcolm R. Sears1Firestone Institute for Respiratory Health, St Joseph’s Healthcare and McMaster University, Hamilton, ON, CanadaFinn Radner2AstraZeneca R&D, Mölndal, Sweden
- Safety of formoterol in asthma clinical trialsBy Malcolm Sears and Finn RadnerMalcolm Sears1Medicine, McMaster University, Hamilton, ON, CanadaFinn Radner2AstraZeneca R&D, AstraZeneca R&D, Molndal, Sweden
- Risk of pneumonia related to budesonide use in COPD: An updated pooled analysisBy Don Sin, Donald Tashkin, Finn Radner, Ulf Sjobring, Anders Thoren, Peter Calverley and Stephen RennardDon Sin1Department of Medicine, University of British Columbia, Vancouver, CanadaDonald Tashkin2Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, Los Angeles, United StatesFinn Radner3Clinical Sciences, AstraZeneca R&D, Molndal, SwedenUlf Sjobring3Clinical Sciences, AstraZeneca R&D, Molndal, SwedenAnders Thoren3Clinical Sciences, AstraZeneca R&D, Molndal, SwedenPeter Calverley4School of Clinical Sciences, University of Liverpool, United KingdomStephen Rennard5Internal Medicine Section of Pulmonary and Critical Care, Nebraska Medical Center, Omaha, United States
- Safety of formoterol in asthma clinical trials: an updateBy Malcolm R. Sears and Finn RadnerArticle | Published in 2013 in European Respiratory JournalMalcolm R. Sears*Firestone Institute for Respiratory Health, St Joseph's Healthcare and McMaster University, Hamilton, Ontario, CanadaFinn Radner#AstraZeneca R&D, Mölndal, Sweden
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
